Loading cancer entity…
Loading cancer entity…
Clinical trials
805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04622631 | Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT | unknown | — | 80 | Dr. Nayruz KnaanaOTHER_GOV | 1 | Nov 10, 2020 | clinicaltrials |
| NCT04621565 | Hydrocortisone Use During Peri-operation for Pituitary Adenomas | unknown | N/A | 436 | Peking Union Medical College HospitalOTHER | 1 | Nov 9, 2020 | clinicaltrials |
| NCT04491851 | Impact of Peptides and Chelators on Somatostatin Receptor Antagonists | unknown | Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT04194125 | Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer | unknown | Phase 2 | 25 | University of Warmia and MazuryOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT04611685 | Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas | unknown | N/A | 202 | Peking Union Medical College HospitalOTHER | 1 | Nov 3, 2020 | clinicaltrials |
| NCT04557137 | Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia | unknown | — | 100 | University of AarhusOTHER | 1 | Sep 21, 2020 | clinicaltrials |
| NCT03881306 | DEBOXA for Inoperable NET Liver Metastases | unknown | Phase 1 / Phase 2 | 60 | Xiangya Hospital of Central South UniversityOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04039516 | Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy(CHARRT) | unknown | Phase 2 | 20 | King's College Hospital NHS TrustOTHER | 0 | Aug 4, 2020 | clinicaltrials |
| NCT04107480 | PRolaCT - Three Prolactinoma RCTs | unknown | Phase 4 | 880 | Leiden University Medical CenterOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT03923777 | Active Surveillance in Early Lung Cancer(ACTION-Lung) | unknown | N/A | 26 | University of Vermont Medical CenterOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT04336839 | Portal Vein Resection in Pancreatic Neuroendocrine Tumours(PVNET) | unknown | — | 40 | Royal Free Hospital NHS Foundation TrustOTHER | 0 | Apr 7, 2020 | clinicaltrials |
| NCT04029428 | Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression(POLNETS_PRRT) | unknown | Phase 2 | 150 | University of Warmia and MazuryOTHER | 1 | Apr 1, 2020 | clinicaltrials |
| NCT03457389 | Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma | unknown | N/A | 68 | Seoul National University HospitalOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT03474601 | Seoul National University Pituitary Disease Cohort Study(SNU-PIT) | unknown | — | 1,600 | Seoul National University HospitalOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT03422029 | Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients | unknown | Phase 2 | 20 | Peking UniversityOTHER | 1 | Feb 7, 2020 | clinicaltrials |
| NCT04185350 | Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma | unknown | Early Phase 1 | 60 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Dec 4, 2019 | clinicaltrials |
| NCT04152928 | Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities | unknown | N/A | 50 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 6, 2019 | clinicaltrials |
| NCT04154241 | Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor | unknown | N/A | 50 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 6, 2019 | clinicaltrials |
| NCT04134832 | Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace Region | unknown | — | 250 | University Hospital, Strasbourg, FranceOTHER | 1 | Oct 22, 2019 | clinicaltrials |
| NCT04066322 | Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment(RMPanNET) | unknown | — | 180 | Fudan UniversityOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT03053999 | Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) | unknown | — | 53 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT04041882 | 68Ga-DOTATATE PET/CT in Neuroendocrine Tumor | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Aug 1, 2019 | clinicaltrials |
| NCT02092714 | Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors | unknown | — | 90 | Fox Chase Cancer CenterOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03982264 | Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm | unknown | N/A | 90 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Jun 11, 2019 | clinicaltrials |
| NCT03963193 | Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type | unknown | Phase 2 | 112 | Henan Cancer HospitalOTHER_GOV | 0 | May 24, 2019 | clinicaltrials |
| NCT03083210 | Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET | unknown | Phase 4 | 28 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03930368 | Application of Raw Corn Starch on Patients With Insulinoma | unknown | N/A | 20 | Peking Union Medical College HospitalOTHER | 1 | Apr 29, 2019 | clinicaltrials |
| NCT03815838 | Molecular Imaging of Pituitary Adenomas(MIMOPA) | unknown | N/A | 20 | Cardiff UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03812939 | Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs | unknown | — | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03749681 | Neuroendocrine Tumors of Old Patients in the West of France(TANGO) | unknown | — | 306 | University Hospital, BrestOTHER | 1 | Nov 21, 2018 | clinicaltrials |
| NCT03717454 | Dopamine D2 Receptors(D2R) Imaging in Prolactinomas | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Nov 20, 2018 | clinicaltrials |
| NCT03714763 | Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA) | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Oct 22, 2018 | clinicaltrials |
| NCT03400865 | Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas | unknown | N/A | 30 | Zhebao WuOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT03689231 | Volumetric Imaging Follow up of Patients With Liver Metastases of Small Intestinal Neuroendocrine Tumors (NETs).(VOLUNET) | unknown | — | 80 | Hospices Civils de LyonOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT03629847 | Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue | unknown | Phase 1 / Phase 2 | 30 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 14, 2018 | clinicaltrials |
| NCT03591315 | Clinical Study of Structural and Functional Evaluation of the Visual Pathway | unknown | — | 60 | Xiangya Hospital of Central South UniversityOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03442959 | Resection of the Primary Tumor vs no Resection in Asymptomatic Patients With Unresectable Synchronous Liver Metastases From siNEN(SI-NET) | unknown | — | 50 | CHU de ReimsOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT03435770 | Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | unknown | N/A | 10 | Singapore General HospitalOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT03417843 | Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.(yes) | unknown | N/A | 20 | HaEmek Medical Center, IsraelOTHER | 0 | Feb 13, 2018 | clinicaltrials |
| NCT03404414 | Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT | unknown | Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Jan 19, 2018 | clinicaltrials |
| NCT03372356 | Psychosocial Screening for Neuroendocrine Tumor Patients | unknown | — | 100 | Peking UniversityOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT03353025 | Study on Therapy of Non-invasive Prolactinoma(TNAPA) | unknown | N/A | 394 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT03308682 | 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors | unknown | Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT03288597 | Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms | unknown | — | 146 | Peking UniversityOTHER | 1 | Sep 20, 2017 | clinicaltrials |
| NCT03130205 | Biomarker Study in Pancreatic Neuroendocrine Tumours(PROGRESS) | unknown | — | 30 | Uppsala UniversityOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT03204019 | A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor | unknown | Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 29, 2017 | clinicaltrials |
| NCT03033186 | Everolimus TDM to Predict Long Term Toxicity(Foresight) | unknown | — | 40 | Maastricht University Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03164148 | Heart Rate Variability (HRV) in Pituitary Adenoma | unknown | N/A | 50 | Seoul St. Mary's HospitalOTHER | 1 | May 23, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Nov 10, 2020source: clinicaltrials